Every ProjMed story ships with clinician, investor, and patient lenses; ELI5 and regulatory depth; and an evidence grade.

Recent advances in tinnitus treatment emphasize combination therapies and neuromodulation, yet sustained relief remains an elusive goal for many patients, highlighting the need for more robust clinical evidence.

Regulatory differences and reimbursement strategies in the UK are shaping the availability and adoption of oral and injectable GLP-1 receptor agonists for weight management, with implications for patient access and market dynamics.